Brief: Jcr Announces Research Collaboration, Option And License Agreement With Alexion
21/12/2023 12:41
Dec 21 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* JCR ANNOUNCES RESEARCH COLLABORATION, OPTION AND LICENSE
AGREEMENT WITH ALEXION ON DISCOVERY OF OLIGONUCLEOTIDE
THERAPEUTICS USING J-BRAIN CARGO® TECHNOLOGY
Source text for Eikon: ID:nBw1X1PLGa
Further company coverage: 4552.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results